KIF5A rabbit pAb

KIF5A rabbit pAb

AO-06-ES15306-100

KIF5A rabbit pAb 100μL

check In Stock
Hurry! only 10 items left in stock.
€429.00
Tax excluded
Quantity

Antibody Product Overview

ELK.NoES15306
Product nameKIF5A rabbit pAb
ReactivityHuman; Mouse;Rat
ApplicationsWB;ELISA;IHC
Other name
Size100μL
Unit price ($)248
Human gene ID3798
Human Swiss-ProtQ12840
SourceRabbit
IsotypeIgG
TargetKIF5A
Fields>>Endocytosis;>>Dopaminergic synapse;>>Alzheimer disease;>>Parkinson disease;>>Amyotrophic lateral sclerosis;>>Huntington disease;>>Prion disease;>>Pathways of neurodegeneration - multiple diseases;>>Salmonella infection;>>Non-small cell lung cancer
Gene nameKIF5A NKHC1
Protein nameKIF5A
Human gene linkView Human Gene
Human Swiss linkView Human Swiss-Prot
Mouse gene ID16572
Mouse gene linkView Mouse Gene
Mouse Swiss-ProtP33175
Mouse Swiss linkView Mouse Swiss-Prot
Rat gene ID314906
Rat gene linkView Rat Gene
Rat Swiss-ProtQ6QLM7
Rat Swiss linkView Rat Swiss-Prot
ImmunogenSynthesized peptide derived from human KIF5A AA range: 213-263
SpecificityThis antibody detects endogenous levels of KIF5A at Human/Mouse/Rat
FormulationLiquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
ClonalityPolyclonal
DilutionWB 1:500-2000;IHC-p 1:50-300; ELISA 2000-20000
PurificationThe antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.
Concentration1 mg/ml
Storage stability-20°C/1 year
Molecular Weight (Da)114kD
Observed band (KD)
BackgroundThis gene encodes a member of the kinesin family of proteins. Members of this family are part of a multisubunit complex that functions as a microtubule motor in intracellular organelle transport. Mutations in this gene cause autosomal dominant spastic paraplegia 10. [provided by RefSeq, Jul 2008],
Functiondisease:Defects in KIF5A are the cause of spastic paraplegia type 10 (SPG10) [MIM:604187]. SPG10 is a form of autosomal dominant hereditary spastic paraplegia (AD-HSP). HSP is a group of inherited degenerative spinal cord disorders characterized by a slow, gradual, progressive weakness and spasticity (stiffness) of the legs. Rate of progression and the severity of symptoms is quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.,domain:Composed of three structural domains: a large globular N-terminal domain which is responsible for the motor activity of kinesin (it hydrolyzes ATP and binds microtubule), a central alpha-helical coiled coi
Subcellular locationCytoplasm, perinuclear region . Cytoplasm, cytoskeleton . Perikaryon . Concentrated in the cell body of the neurons, particularly in the perinuclear region. .
ExpressionDistributed throughout the CNS but is highly enriched in subsets of neurons.

Additional Images

Image 1
No image
Western blot analysis of lysates from MCF-7 cells, primary antibody was diluted at 1:1000, 4°over night
Image 2
No image
Immunohistochemical analysis of paraffin-embedded human Gastric adenocarcinoma. 1, Antibody was diluted at 1:200(4° overnight). 2, Tris-EDTA,pH9.0 was used for antigen retrieval. 3,Secondary antibody was diluted at 1:200(room temperature, 45min).
No image
No image
: AO-06-ES15306-100
: 10 Items
Hurry! only 10 items left in stock.

Use collapsible tabs for more detailed information that will help customers make a purchasing decision.

Ex: Shipping and return policies, size guides, and other common questions.

  • Paste the label on a flat surface on the package
  • Make sure that both 1D and 2D barcodes are clearly visible
  • Ensure that the label is smooth and isn’t creased or wrinkled
  • Check for any tears, dents, holes or scratches
  • Pack your product tightly, with the right size packaging
  • Ensure both barcodes are on a flat surface of the package